Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. - Wikidata - wikimedia - TriplyDB

Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

http://www.wikidata.org/entity/Q33504706

about

A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli Pathophysiology of the antiphospholipid syndrome Domain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318 Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides.Pharmacokinetics of LJP 993, a tetrameric conjugate of domain 1 of beta2-glycoprotein I for antiphospholipid syndrome Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of beta2-glycoprotein I.Accelerated atheroma and anti-beta2-glycoprotein I antibodies.Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.New therapeutic targets for the antiphospholipid syndrome.Monoclonal antibodies and other biologic therapies.Autoantibodies directed against domain I of beta2-glycoprotein I.Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1.Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis.Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease.Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis "New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion.LJP 1082: a toleragen for Hughes syndrome.Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43 Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome Antiphospholipid syndrome: laboratory testing and diagnostic strategies.The antiphospholipid syndrome: still an enigma Recent advances in understanding antiphospholipid syndrome.Domain I of beta2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome.Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK.Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.Recent developments in our understanding of the antiphospholipid syndrome.Pathophysiology of thrombotic APS: where do we stand?Antibodies against domain I of β2-glycoprotein I: the one and only?Anti-β2-glycoprotein I antibodies.New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies.Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review.Immunotherapeutic strategies in antiphospholipid syndrome.Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome.Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.

P2860

Q25255895-8809087A-F32C-4F2A-8FE5-5D355D8F6D52 Q28267421-8B2C1733-7EF0-412C-89B9-EFE47194B362 Q28291393-EC92A293-4DF6-4976-96DB-CA4DA1D5AA31 Q30497721-62DFCD64-D28C-49F4-A709-CCB2B2B07428 Q30676844-95C12683-BEAB-49BB-85A7-2B845AC5869A Q33698159-3B1603EB-93BF-4E43-8D03-725D3E950E27 Q33844273-99CB8CEF-F398-4BA5-B364-A72A181DD212 Q33915467-8AB27495-7118-4639-BE09-1D6EBC847EE6 Q33948737-E8D3E3D2-7A1D-48BD-9562-F723C2D241FE Q34069117-BAB2BC41-6C03-43D5-AE48-22F61EBBA720 Q34140319-ED92DBD9-4017-4551-8643-5CB7DAEE8890 Q34227074-E1A47A4C-D0D7-4251-9D95-3E5B337CEC73 Q34467454-6D22687A-DC11-4D99-AF2E-363150771754 Q34474881-DEA6D062-4A92-4337-BC91-744CB369AF4A Q34790028-EDA42835-0121-4F9E-B49E-F60B74F9A67A Q35181703-4EC0DF17-67D8-4C7F-BA72-C415E8A33BFA Q35214636-054A07CB-BDAD-4514-A6CA-EEF468651886 Q35250419-B0B16F44-6EFE-4073-B860-364997A4F458 Q35535795-7B9E565F-E84F-4770-97B6-0809D985E9E9 Q35824487-8C44D99E-D70A-4C38-8B5E-E3778993EFEA Q35843950-707DF978-31F4-4FC5-ABB6-399D33FE9A11 Q36037794-D1AC9DF0-E4AC-43F7-9520-B1273AFCC29B Q36225236-59EB921D-FA43-4454-A054-4FE82CF93BBE Q36774243-628E4BE6-C6FA-4B4C-99D3-C82AD86CEB26 Q36844544-395F4C8B-A1BD-41C1-A01F-E727CC23C73C Q36928593-C7290FA1-1998-46DD-B15B-82D55069E3BA Q37577693-5C3EC6C1-D4B4-4EE1-8FF1-5A26B2CF8E18 Q37721607-D84349D3-624F-49BD-A7B1-53052E6AEFE4 Q37744837-0CD4591F-EFCB-452B-8AD2-04E5457382A3 Q37903952-C3A98B87-81C0-41BB-B88F-06F4CD9DFFF9 Q37991066-3B90506C-7C6B-43EA-B8D5-D2F8A680E32E Q38013582-D2B75190-4DEF-4BB5-866E-1A9962C158DE Q38013590-B627C14A-CD73-43EF-9126-29909DC5597B Q38108396-FF3751EE-8185-4DE0-9ACA-2FC962C0CF23 Q38175886-890A8CB6-CE9A-4FC6-86EE-13EBA768FD59 Q38596401-301DE464-89A4-42EE-9131-F1996FE469E5 Q38826804-205A3307-E03D-4DB5-959B-81BDE2565B32 Q39044818-A327E15E-53C4-47FC-AE59-60C601809D16 Q39716593-DC895DCB-08FC-4B5B-805C-0F6F1FF2DFAD Q40858020-AF8C94B3-D60F-44E9-BAE6-1D4C64EB6883

P2860

Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

http://www.wikidata.org/entity/Q33504706

description

1998 nî lūn-bûn

@nan

1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Anti-beta2 glycoprotein I (bet ...... the first domain of beta2GPI.

@ast

Anti-beta2 glycoprotein I (bet ...... the first domain of beta2GPI.

@en

type

label

Anti-beta2 glycoprotein I (bet ...... the first domain of beta2GPI.

@ast

Anti-beta2 glycoprotein I (bet ...... the first domain of beta2GPI.

@en

prefLabel

Anti-beta2 glycoprotein I (bet ...... the first domain of beta2GPI.

@ast

Anti-beta2 glycoprotein I (bet ...... the first domain of beta2GPI.

@en

P1433

Q33504706-435AAB97-015F-48C3-B482-B7136D3E5EB7

P1476

Q33504706-AB495FC0-61C4-4348-876F-686118042616

P2093

Q33504706-8184ACCF-11E7-4145-A208-16220A2D1EC8

Q33504706-87353E14-75AC-47CC-AF03-26B115A69197

Q33504706-AC8EB3C0-A627-4A83-AD84-ADDE11AE5F6F

P2860

Q33504706-09DB32CD-9614-4382-976E-A277D5E9CF1F

Q33504706-3182EA04-12C5-4E33-A688-B4C5F9D2D166

Q33504706-38F5D63E-B341-4B88-8858-9FE5504AE0FA

Q33504706-46955669-36E9-47D7-869E-6296B781A2F1

Q33504706-53E03EEA-7856-427C-A78C-2E2EAE9ABC21

Q33504706-5DB0A680-E68D-4184-B251-A5DD7F911800

Q33504706-86F5B220-7B17-48F3-B832-F4D7E6D68B92

Q33504706-91108AA7-95F1-4A5A-BF73-04DDFCD5ABFE

Q33504706-9415BE3C-1ED8-4460-A805-EAB250683A0B

Q33504706-C0516CE5-04E6-4C8C-BD72-10AA86E59531

P304

Q33504706-9B9AB9CD-8C81-440D-84CB-AF0EB5B730A8

P31

Q33504706-6DBD2FDE-3943-4195-A55C-2C9BA063FA7C

P356

Q33504706-86AA937A-997D-4F27-870C-896304F11E1E

P407

Q33504706-6E6624B3-CA98-4764-835B-B72139D833CA

P433

Q33504706-D9A50062-A54C-4E72-B924-76F6FE274072

P478

Q33504706-64FB4F58-02ED-4E2A-A1F1-DEE0DCBAB044

P577

Q33504706-BFB5C870-D27E-427F-BCA3-F98D14D0CC47

P5875

Q33504706-C0130943-C620-4412-8553-0682D0B469C1

P698

Q33504706-E5C3C19C-340F-49B7-B3F0-B13F80466E97

P921

Q33504706-934DE74C-9E57-4DA6-A9C2-E6866F4757FB

P932

Q33504706-51A76069-7389-43E5-8EC0-1C5915E15315

P356

PNAS.95.26.15542

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Anti-beta2 glycoprotein I (bet ...... the first domain of beta2GPI.

@en

P2093

Iverson GM

http://www.w3.org/2001/XMLSchema#string

Marquis DM

http://www.w3.org/2001/XMLSchema#string

Victoria EJ

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

Rapid and efficient site-specific mutagenesis without phenotypic selection

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody

Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity

Complete amino acid sequence of human plasma beta 2-glycoprotein I.

Structure of transglutaminases.

Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system.

P304

15542-15546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.26.15542

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235612628

http://www.w3.org/2001/XMLSchema#string

P698

9861005

http://www.w3.org/2001/XMLSchema#string

P921

P932

28079

http://www.w3.org/2001/XMLSchema#string